Dr. James B. Deville, MD
Cardiac Electrophysiology (Clinical Cardiac Electrophysiology Physician)
- Medicare participating
At a glance
- Medical school
- Louisiana State University School of Medicine in Shreveport (1988)
- Years since graduation
- 38
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 663
Licensed in Texas since 1992, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1988Medical school: Louisiana State University School of Medicine in Shreveport
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Clinical Cardiac Electrophysiology Physician primary
TX license J1650 (first issued 1992; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Baylor Scott & White Medical Center Plano Plano, TX
- Baylor Scott & White the Heart Hospital Plano Plano, TX
Medical groups
- Healthtexas Provider Network (2,697 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 663
- Services billed
- 3,996
- Patients’ average age
- 77
| Service | Times | Patients |
|---|---|---|
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 628 | 245 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 382 | 161 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 344 | 118 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 260 | 89 |
| Programming of dual lead pacemaker system | 253 | 136 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 164 | 30 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 161 | 36 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 139 | 127 |
| Established patient office or other outpatient visit, 30-39 minutes | 135 | 120 |
| Programming of multiple lead implantable defibrillator system | 95 | 54 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Eliquis (apixaban) Other prescribers in Plano, TX | 159 |
| Metoprolol Succinate Other prescribers in Plano, TX | 60 |
| Xarelto (rivaroxaban) Other prescribers in Plano, TX | 53 |
| Flecainide Acetate Other prescribers in Plano, TX | 53 |
| Tramadol Hcl Other prescribers in Plano, TX | 38 |
| Acebutolol Hcl | 27 |
| Metoprolol Tartrate Other prescribers in Plano, TX | 21 |
| Sotalol (sotalol hcl) Other prescribers in Plano, TX | 16 |
| Carvedilol Other prescribers in Plano, TX | 13 |
| Mexiletine Hcl | 11 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 6 companies reported 34 payments worth $16,035 in total to this clinician.
| Biosense Webster, Inc. | $11,650 |
|---|---|
| Medtronic, Inc. | $3,385 |
| Abbott Laboratories | $580 |
| Ebr Systems, Inc. | $222 |
| Boston Scientific Corporation | $175 |
| Cordis US Corp. | $22.25 |
| Consulting Fee | $8,550 |
|---|---|
| Travel and Lodging | $3,240 |
| Compensation for services other than consulting (speaking, faculty) | $3,150 |
| Food and Beverage | $1,095 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Biosense Webster, Inc. Dec 19, 2025 | Consulting Fee CARTO 3 · Cardiology | $3,600 |
| Medtronic, Inc. Nov 18, 2025 | Compensation for services other than consulting (speaking, faculty) AFFERA MAPPING SYSTEM · Ablation | $3,150 |
| Biosense Webster, Inc. Jul 24, 2025 | Consulting Fee CARTO 3 · Cardiology | $1,800 |
| Biosense Webster, Inc. Nov 21, 2025 | Consulting Fee CARTO 3 · Cardiology | $1,350 |
| Biosense Webster, Inc. Sep 23, 2025 | Travel and Lodging CARTO 3 · Cardiology · travel to Carlsbad, CA · in-kind | $998 |
| Biosense Webster, Inc. Nov 24, 2025 | Consulting Fee CARTO 3 · Cardiology | $900 |
| Biosense Webster, Inc. Sep 29, 2025 | Travel and Lodging CARTO 3 · Cardiology · travel to Carlsbad, CA · in-kind | $700 |
| Biosense Webster, Inc. Sep 29, 2025 | Travel and Lodging CARTO 3 · Cardiology · travel to Carlsbad, CA · in-kind | $475 |
| Biosense Webster, Inc. Sep 26, 2025 | Travel and Lodging CARTO 3 · Cardiology · travel to Carlsbad, CA · in-kind | $457 |
| Biosense Webster, Inc. Jun 16, 2025 | Consulting Fee CARTO 3 · Cardiology | $450 |
All 14 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Biosense Webster, Inc. Dec 19, 2025 | Consulting Fee CARTO 3 · Cardiology | $3,600 |
| Biosense Webster, Inc. Nov 24, 2025 | Consulting Fee CARTO 3 · Cardiology | $900 |
| Biosense Webster, Inc. Nov 21, 2025 | Consulting Fee CARTO 3 · Cardiology | $1,350 |
| Biosense Webster, Inc. Nov 21, 2025 | Consulting Fee CARTO 3 · Cardiology | $450 |
| Medtronic, Inc. Nov 18, 2025 | Compensation for services other than consulting (speaking, faculty) AFFERA MAPPING SYSTEM · Ablation | $3,150 |
| Biosense Webster, Inc. Nov 1, 2025 | Travel and Lodging CARTO 3 · Cardiology · travel to Carlsbad, CA · in-kind | $367 |
| Biosense Webster, Inc. Sep 29, 2025 | Travel and Lodging CARTO 3 · Cardiology · travel to Carlsbad, CA · in-kind | $700 |
| Biosense Webster, Inc. Sep 29, 2025 | Travel and Lodging CARTO 3 · Cardiology · travel to Carlsbad, CA · in-kind | $475 |
| Biosense Webster, Inc. Sep 26, 2025 | Travel and Lodging CARTO 3 · Cardiology · travel to Carlsbad, CA · in-kind | $457 |
| Biosense Webster, Inc. Sep 23, 2025 | Travel and Lodging CARTO 3 · Cardiology · travel to Carlsbad, CA · in-kind | $998 |
| Biosense Webster, Inc. Jul 24, 2025 | Consulting Fee CARTO 3 · Cardiology | $1,800 |
| Biosense Webster, Inc. Jun 16, 2025 | Consulting Fee CARTO 3 · Cardiology | $450 |
| Abbott Laboratories May 20, 2025 | Travel and Lodging AVEIR · Structural Heart · travel to Dallas, TX · in-kind | $234 |
| Abbott Laboratories May 20, 2025 | Travel and Lodging AVEIR · Structural Heart · travel to Dallas, TX · in-kind | $9.02 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 5 industry-funded studies in 2025, from 4 companies. The companies reported $107,974 in research payments for these studies, mostly to the institutions running them.
- CHAMPION-AF Clinical Trial
Boston Scientific Corporation · Active, not recruiting · NCT04394546 - Safety and Effectiveness Evaluation of the THERMOCOOL SMARTTOUCH(TM) SF Catheter with the TRUPULSE(TM) Generator for treatment of the Paroxysmal Atrial Fibrillation
Biosense Webster, Inc. - Comparison of Anticoagulation With Left Atrial Appendage Closure After AF Ablation
Boston Scientific Corporation · Completed · NCT03795298 - PSR-CVG
Medtronic, Inc. - Dose-finding, Pharmacokinetics, and Safety of VABOMERE in Pediatric Subjects With Bacterial Infections
Melinta Therapeutics, LLC · Completed · NCT02687906
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.